{"adrenal insufficiency": 145.1, "central hypothyroidism": 632.21, "disease progression": 6.35, "hypothyroidism": 14.39, "malignant neoplasm progression": 11.53, "mineralocorticoid deficiency": 25076.64, "off label use": 15.81, "product use in unapproved indication": 8.36}